Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Special Features of Adaptive Immunity01:20

Special Features of Adaptive Immunity

3.7K
The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
3.7K
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

3.0K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
3.0K
Hypersensitivities01:30

Hypersensitivities

7.3K
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
7.3K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

64.7K
Overview
64.7K
Allergic Drug Reactions01:27

Allergic Drug Reactions

1.6K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.6K
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

209
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
209

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-term disability outcomes in Hansen's disease: A 20-year comparative study of Lepromatous vs. Tuberculoid Leprosy.

PLoS neglected tropical diseases·2026
Same author

CD1a-Mediated Presentation of Canonical Microbial Peptides to T Cells.

bioRxiv : the preprint server for biology·2026
Same author

Notch1 deletion reduces arrhythmogenic remodeling after myocardial infarction.

Heart rhythm·2026
Same author

GLP-1RAs and cardiovascular risk reduction in psoriasis: A retrospective cohort study.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Same author

Sotatercept Reverses SIN3a Deficiency-Driven PAH by Reprogramming BMPR2/TGF-β-HIF-1α Signaling Pathways.

bioRxiv : the preprint server for biology·2026
Same author

Epigenetic reprogramming drives endothelial dysfunction via neuropilin-1 in pulmonary hypertension.

Molecular medicine (Cambridge, Mass.)·2025

Related Experiment Video

Updated: Apr 30, 2026

Optimized Protocols for Mycobacterium leprae Strain Management: Frozen Stock Preservation and Maintenance in Athymic Nude Mice
10:32

Optimized Protocols for Mycobacterium leprae Strain Management: Frozen Stock Preservation and Maintenance in Athymic Nude Mice

Published on: March 23, 2014

18.2K

Recognizing and managing the immunologic reactions in leprosy.

Sonia Kamath1, Seth A Vaccaro1, Thomas H Rea1

  • 1Department of Dermatology, Keck School of Medicine, University of Southern California, Los Angeles, California.

Journal of the American Academy of Dermatology
|April 29, 2014
PubMed
Summary

Leprosy reactions, including reversal reaction (type 1) and erythema nodosum leprosum (type 2), significantly impact disease course and disability. Early recognition and treatment with medications like prednisone and thalidomide are crucial for managing these immunologic complications.

Keywords:
Hansen diseaseLucio phenomenonerythema nodosum leprosumleprosyreversal reactiontype 1 reactiontype 2 reaction

More Related Videos

Immunometabolic Circuits in Infection for Advancing Host Directed Therapies
11:12

Immunometabolic Circuits in Infection for Advancing Host Directed Therapies

Published on: September 13, 2024

1.1K
The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice
12:04

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice

Published on: November 1, 2015

17.7K

Related Experiment Videos

Last Updated: Apr 30, 2026

Optimized Protocols for Mycobacterium leprae Strain Management: Frozen Stock Preservation and Maintenance in Athymic Nude Mice
10:32

Optimized Protocols for Mycobacterium leprae Strain Management: Frozen Stock Preservation and Maintenance in Athymic Nude Mice

Published on: March 23, 2014

18.2K
Immunometabolic Circuits in Infection for Advancing Host Directed Therapies
11:12

Immunometabolic Circuits in Infection for Advancing Host Directed Therapies

Published on: September 13, 2024

1.1K
The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice
12:04

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice

Published on: November 1, 2015

17.7K

Area of Science:

  • Immunology
  • Dermatology
  • Infectious Diseases

Background:

  • Leprosy immunologic reactions significantly influence disease progression and patient disability.
  • Key reactions include reversal reaction (type 1), erythema nodosum leprosum (type 2), and Lucio phenomenon.
  • These reactions are most prevalent in lepromatous and borderline leprosy, common forms in the United States.

Purpose of the Study:

  • To highlight the importance of recognizing and managing leprosy reactions for physicians in the US.
  • To discuss the timing of reactions relative to multidrug therapy.
  • To outline potential therapeutic strategies for mitigating symptoms and preventing disability.

Main Methods:

  • Review of the clinical presentation and impact of leprosy reactions.
  • Discussion of the role of immunologic responses in disease pathogenesis.
  • Overview of current, albeit limited, treatment approaches for leprosy reactions.

Main Results:

  • Reversal reactions are the primary cause of nerve damage in leprosy; erythema nodosum leprosum can also cause neuritis.
  • Leprosy reactions can manifest before, during, or after multidrug therapy.
  • Prednisone and thalidomide show potential in managing symptoms and preventing disability associated with these reactions.

Conclusions:

  • Effective management of leprosy reactions is essential for improving patient outcomes and reducing long-term disability.
  • Further research is needed to establish definitive, evidence-based treatment regimens.
  • Physician awareness and prompt intervention are critical for patients with lepromatous and borderline leprosy.